Holen Sie sich die Stockscreener-App
6.93
1.00%
-0.07
Schlusskurs vom Vortag:
$7.00
Offen:
$6.912
24-Stunden-Volumen:
516
Relative Volume:
0.11
Marktkapitalisierung:
$8.54M
Einnahmen:
$364.30K
Nettoeinkommen (Verlust:
$-8.27M
KGV:
-0.7969
EPS:
-8.6961
Netto-Cashflow:
$-2.00M
1W Leistung:
+5.16%
1M Leistung:
+21.16%
6M Leistung:
-26.28%
1J Leistung:
-14.13%
1-Tages-Spanne:
$6.912
$6.93
1-Wochen-Bereich:
$6.18
$7.23
52-Wochen-Spanne:
$5.41
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Firmenname
Addex Therapeutics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare ADXN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
6.93 | 8.62M | 364.30K | -8.27M | -2.00M | -8.6961 |
VRTX
Vertex Pharmaceuticals Inc
|
427.29 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
708.32 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
805.30 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
293.90 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.99 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Aktie (ADXN) Neueste Nachrichten
Earnings call transcript: Addex Therapeutics H2 2026 reveals strategic shifts By Investing.com - Investing.com India
Earnings call transcript: Addex Therapeutics H2 2026 reveals strategic shifts - Investing.com
Addex Therapeutics Q4 2025 Earnings Call Transcript - Sahm
Addex Therapeutics announces GABAB PAM candidate data - TipRanks
Addex Therapeutics says spin-out company to complete NTX-253 study in Q2 - TipRanks
Addex Therapeutics Short Interest Drops in March - National Today
JX Luxventure Group Inc (NASDAQ:JXG) Short Interest Up 140.3% in February - Defense World
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8% - Defense World
SPDR SSgA Multi-Asset Real Return ETF (NYSEARCA:RLY) Short Interest Up 142.0% in February - Defense World
Short Interest in Intrum AB (publ) (OTCMKTS:ITJTY) Grows By 140.2% - Defense World
Breakwave Tanker Shipping ETF (NYSEARCA:BWET) Short Interest Update - Defense World
Solidion Technology Inc. (NASDAQ:STI) Sees Significant Growth in Short Interest - Defense World
Addex Therapeutics (NASDAQ:ADXN) Trading 2% Higher – Here’s Why - Defense World
Addex publishes negative allosteric modulators data in Molecular Psychiatry - TipRanks
CGX Energy (CVE:OYL) Shares Up 17.2% – Should You Buy? - Defense World
FedEx Corporation $FDX Shares Purchased by Transcend Capital Advisors LLC - Defense World
Orex Minerals (CVE:REX) Shares Down 22.8% – What’s Next? - Defense World
Paycom Software (NYSE:PAYC) Price Target Lowered to $210.00 at UBS Group - Defense World
Addex Therapeutics (ADXN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Addex Therapeutics earnings call: Progress amidst financial challenges - MSN
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - The Globe and Mail
Addex Therapeutics Reports Q3 2025 Financial Results - The Globe and Mail
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings - Investing.com India
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Total debt per share of Addex Therapeutics Ltd Sponsored ADR – MUN:APE1 - TradingView
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 5.5% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
How geopolitical risks impact Addex Therapeutics Ltd (APE) stockShare Buyback & Consistent Growth Equity Picks - newser.com
[F-3] Addex Therapeutics Ltd. Foreign Issuer Shelf Registration | ADXN SEC FilingForm F-3 - Stock Titan
Why Addex Therapeutics Ltd (APE) stock stays on buy listsJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Addex Therapeutics (NASDAQ:ADXN) Shares Up 5.6% – Here’s What Happened - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - The Globe and Mail
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Addex Therapeutics Ltd Stock Price Today | NASDAQ: ADXN Live - Investing.com
Addex Therapeutics Ltd_December 31, 2024 - SEC.gov
Aspire Biopharma (ASBP) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Addex Stock Soars on Crucial Update From Indivior Research Deal - Yahoo Finance
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2026 - MarketBeat
Barinthus Biotherapeutics plc (BRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - CNN
Psyence Biomedical (PBM) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
60 Degrees Pharmaceuticals (SXTP) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
What is the current Price Target and Forecast for Addex Therapeutics (ADXN) - Zacks Investment Research
Most VolatileStock ScreenerNews - Finviz
Ernexa Therapeutics (ERNA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Trading Halts Explained - MarketBeat
Corbus Pharmaceuticals (CRBP) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Finanzdaten der Addex Therapeutics Ltd Adr-Aktie (ADXN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
2.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):